We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$3.49B
AUM Growth
+$308M
Cap. Flow
-$82.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
56.89%
Holding
645
New
145
Increased
110
Reduced
156
Closed
135
Avg Time Held Equity + Options
4.1 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
4.4 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
1 quarter

Top Buys

Rank Stock Value
1
JNPR icon
Juniper Networks
JNPR
+$162M
2
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$128M
3
ANSS icon
Ansys
ANSS
+$119M
4
X icon
US Steel
X
+$104M
5
CTLT icon
CATALENT, INC.
CTLT
+$93.3M

Top Sells

Rank Stock Value
1
SPLK icon
Splunk Inc
SPLK
+$561M
2
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$120M
3
IMGN icon
Immunogen Inc
IMGN
+$56.8M
4
CPRI icon
Capri Holdings
CPRI
+$44.2M
5
PXD icon
Pioneer Natural Resource Co.
PXD
+$34M

Sector Composition

Rank Sector Weight
1 Energy 34.28%
2 Technology 15.43%
3 Healthcare 14.7%
4 Industrials 8%
5 Miscellaneous 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RAPT icon
301
DELISTED
RAPT Therapeutics
RAPT
$656K 0.02%
9,136
+1,400
+18% +$195K
2022 Q2
7 quarters
PRCT icon
302
Procept Biorobotics
PRCT
$1.05B
$653K 0.02%
13,217
-6,500
-33% -$309K
2022 Q4
5 quarters
COTY icon
303
PUT
Coty
COTY
$2.51B
$639K 0.02%
1,364,500
-53,500
-4% -$653K
2023 Q3
2 quarters
TEVA icon
304
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
$633K 0.02%
44,896
-45,121
-50% -$569K
2023 Q3
2 quarters
BOLD icon
305
Boundless Bio
BOLD
$58.5M
$594K 0.02%
+41,650
New +$594K
2024 Q1
0 quarters
OSI icon
306
DELISTED
Osiris Acquisition Corp.
OSI
$589K 0.02%
55,585
– –
2021 Q3
10 quarters
IFRX icon
307
InflaRx
IFRX
$236M
$589K 0.02%
382,409
+180,529
+89% +$295K
2023 Q2
3 quarters
VRNA
308
DELISTED
Verona Pharma
VRNA
$584K 0.02%
36,305
-12,228
-25% -$211K
2022 Q3
6 quarters
ALT icon
309
Altimmune
ALT
$508M
$578K 0.02%
56,795
+22,497
+66% +$229K
2023 Q4
1 quarter
CARG icon
310
CarGurus
CARG
$2.57B
$577K 0.02%
+25,000
New +$578K
2024 Q1
0 quarters
ZYME icon
311
Zymeworks
ZYME
$1.85B
$573K 0.02%
54,457
-81,856
-60% -$909K
2022 Q2
7 quarters
KALA icon
312
KALA BIO
KALA
$5.68M
$569K 0.02%
+1,451
New +$539K
2024 Q1
0 quarters
BHAC icon
313
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$568K 0.02%
54,209
– –
2021 Q4
9 quarters
VSTM icon
314
Verastem
VSTM
$759M
$546K 0.02%
46,232
-15,571
-25% -$180K
2022 Q1
8 quarters
BIIB icon
315
Biogen
BIIB
$33.3B
$539K 0.02%
2,500
-2,379
-49% -$557K
2023 Q3
2 quarters
CPNG icon
316
Coupang
CPNG
$28.4B
$534K 0.02%
+30,000
New +$491K
2024 Q1
0 quarters
ANNX icon
317
CALL
Annexon
ANNX
$762M
$532K 0.02%
+418,500
New +$2.17M
2024 Q1
0 quarters
AURA icon
318
Aura Biosciences
AURA
$678M
$529K 0.02%
67,325
-22,675
-25% -$188K
2023 Q2
3 quarters
COO icon
319
Cooper Companies
COO
$10.3B
$526K 0.02%
+5,189
New +$502K
2024 Q1
0 quarters
DNLI icon
320
Denali Therapeutics
DNLI
$3.11B
$514K 0.01%
25,033
-9,431
-27% -$177K
2023 Q2
3 quarters
ALC icon
321
Alcon
ALC
$31B
$504K 0.01%
+6,054
New +$486K
2024 Q1
0 quarters
SHOP icon
322
Shopify
SHOP
$220B
$502K 0.01%
+6,500
New +$514K
2024 Q1
0 quarters
ALGS icon
323
Aligos Therapeutics
ALGS
$33.3M
$490K 0.01%
+20,000
New +$398K
2024 Q1
0 quarters
SLRN icon
324
DELISTED
ACELYRIN
SLRN
$482K 0.01%
71,412
+11,412
+19% +$86.7K
2023 Q4
1 quarter
AVBP icon
325
ArriVent BioPharma
AVBP
$825M
$468K 0.01%
+26,181
New +$528K
2024 Q1
0 quarters
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2024 Portfolio in Review

As of Q1 2024, UBS O'Connor held 645 positions worth $3.49B, up 9.7% from $3.18B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

UBS O'Connor's Q1 2024 filing shows 145 new, 110 increased, 156 reduced and 135 closed positions. Its largest new stake was Juniper Networks: 4,428,704 shares worth $164M. The largest sale was Splunk Inc, an estimated $561M.

By sector, the portfolio is most concentrated in Energy at 34% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q1 2024 buy was Juniper Networks: 4,428,704 shares worth $164M.
  • UBS O'Connor added most to Axonics, Inc. Common Stock in Q1 2024, an estimated $128M increase.
  • UBS O'Connor's biggest Q1 2024 reduction was Pioneer Natural Resource Co., cutting an estimated $34M.
  • UBS O'Connor fully exited Splunk Inc in Q1 2024, selling an estimated $561M.
  • UBS O'Connor's ten largest holdings make up 57% of its $3.49B portfolio in Q1 2024.
  • UBS O'Connor opened 145 new positions and closed 135 in Q1 2024.
  • UBS O'Connor's portfolio value rose 9.7% quarter-over-quarter to $3.49B.

Based on UBS O'Connor's 13F filing for Q1 2024, filed 15 May 2024.